Patents by Inventor Heidrun Moll

Heidrun Moll has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8173673
    Abstract: Anti-infective and biofilm-inhibiting activities of aryl isoquinoline-derivatives of the general formulae 1 to 3 are described.
    Type: Grant
    Filed: September 27, 2007
    Date of Patent: May 8, 2012
    Assignee: Julius-Maximilians-Universitaet Wuerzburg
    Inventors: Gerhard Bringmann, Tanja Gulder, Ute Hentschel, Frank Meyer, Heidrun Moll, Joachim Morschhäuser, Alicia Ponte-Sucre De Vanegas, Wilma Ziebuhr, August Stich, Reto Brun, Werner E. G. Müller, Virima Mudogo
  • Publication number: 20100286198
    Abstract: Anti-infective and biofilm-inhibiting activities of aryl isoquinoline-derivatives of the general formulae 1 to 3 are described.
    Type: Application
    Filed: September 27, 2007
    Publication date: November 11, 2010
    Inventors: Gerhard Bringmann, Tanja Gulder, Ute Hentschel, Frank Meyer, Heidrun Moll, Joachim Morschhäuser, Alicia Ponte-Sucre De Vanegas, Wilma Ziebuhr, August Stich, Reto Brun, Werner E.G. Müller, Virima Mudogo
  • Publication number: 20060228342
    Abstract: Described is a method for the generation of antigen-presenting cells (APC), preferably bone marrow-derived dendritic cells (BMDC) or peripheral blood-derived dendritic cells, as antigen carrier having immunostimulatory properties for anti-infective treatment comprising the steps of (a) pulsing the APC with antigen and (b) treating the APC with a CpG oligonucleotide. Said APC are useful as an immune prophylactic or immune therapeutic agent against diseases like AIDS, tuberculosis, malaria or leishmaniasis.
    Type: Application
    Filed: May 27, 2003
    Publication date: October 12, 2006
    Inventors: Robinson Ramirez-Pineda, Heidrun Moll
  • Publication number: 20050244421
    Abstract: A method of modulating reactivity of a T cell population of a mammal comprises contacting the T cell population with an immunogenic dose of an antigenic peptide having a sequence that derives from a tissue specific expressed allelic protein variant from an individual of a specific species, wherein the tissue specific expressed allelic protein is encoded by a DNA sequence containing at least one single nucleotide polymorphism (SNP) in the coding region and binds to a MHC class I protein complex inducing an immunogenic response.
    Type: Application
    Filed: December 13, 2004
    Publication date: November 3, 2005
    Inventors: Wolfgang Strittmatter, Heidrun Moll, Burkhard Scharm